Cigna: US Adalimumab Prices Could Vary Meaningfully
‘A Lot Of Dust Needs To Settle,’ US Insurance Giant Says
Executive Summary
Cigna has responded to several questions from the insurer/payer side on the potential effect of multiple biosimilar Humira products launching in 2023 and beyond.